Nielka van Erp

Development of a Pharmacokinetic Model to Describe the Complex Pharmacokinetics of Pazopanib in Cancer Patients

Nielka van Erp, Sander Bins, Ron H.J. Mathijssen et al. · Clinical Pharmacokinetics · 2016 · 49 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Simultaneous quantitation of abiraterone, enzalutamide, N -desmethyl enzalutamide, and bicalutamide in human plasma by LC–MS/MS

Kyu‐pyo Kim, Robert A. Parise, Julianne L. Holleran et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice

Eveline Wallenburg, Bas Klok, Karin de Jong et al. · Therapeutic Drug Monitoring · 2017 · 28 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients

Sander Bins, Alwin D. R. Huitema, Pim Laven et al. · Clinical Pharmacokinetics · 2018 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Effect of Cigarette Smoking on Imatinib in Patients in the Soft Tissue and Bone Sarcoma Group of the EORTC

Nielka van Erp, Hans Gelderblom, M. van Glabbeke et al. · Clinical Cancer Research · 2008 · 25 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13